Concepedia

David H. Boldt

DH

Statistics

Publications

55

Citations

3.4K

H-Index

33

Active since

1972

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Murphy Oil Corporation (United States)

Walter Reed Army Institute of Research

Audie L. Murphy Memorial VA Hospital

South Texas Veterans Health Care System

David H. Boldt is an author at The University of Texas at San Antonio Health Science Center specializing in life sciences, immunology, and medicine.

Publications per year

1972–2023

55

Publications

55

Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

Bruce D. Cheson, John M. Bennett, Michael R. Grever et al. · American Journal of Hematology · 1988 · 407 citations

, , +16

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.

C. Kent Osborne, David H. Boldt, Gary M. Clark et al. · PubMed · 1983 · 278 citations

, , +16

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

Janice P. Dutcher, Stephen P. Creekmore, Geoffrey R. Weiss et al. · Journal of Clinical Oncology · 1989 · 236 citations

, , +17

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.

Geoffrey R. Weiss, Kim Margolin, Frederick R. Aronson et al. · Journal of Clinical Oncology · 1992 · 159 citations

, , +17

Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen

John Rogers, David H. Boldt, Stuart Kornfeld et al. · Proceedings of the National Academy of Sciences · 1972 · 156 citations

, , +8

1–5 of 55